Cardiol Therapeutics Inc. Class ACRDL

13F holders, Q3 2024 (September 30)
41holders
10new positions
9sold out
1famous investor
$1.98avg. 13F price*

At the end of Q3 2024, 41 institutions reported holding Cardiol Therapeutics Inc. Class A (CRDL) in their 13F filings, unchanged from Q2 2024. 10 opened new positions and 9 sold out. The largest holders were Tejara Capital Ltd ($3.5M), AdvisorShares Investments LLC ($2.3M) and MMCAP International Inc. SPC ($1.6M). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Cardiol Therapeutics Inc. Class A
CUSIP
14161Y200
Latest filing quarter
Q2 2026

History

Number of 13F holders

0204060 Q1 2024: 35Q1 2024Q2 2024: 41Q2 2024Q3 2024: 41Q3 2024Q4 2024: 43Q4 2024Q1 2025: 38Q1 2025Q2 2025: 38Q2 2025Q3 2025: 48Q3 2025Q4 2025: 41Q4 2025Q1 2026: 47Q1 2026Q2 2026: 52Q2 2026

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions10$259K
Exits9$410K

All 13F filers, Q2 2024 → Q3 2024: 362,666 shares bought and 766,311 shares sold, net −403,645 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 41 holders

Tejara Capital Ltd 1.67% Add +2.9% 1,771,270 $3.5M
AdvisorShares Investments LLC 0.44% Reduce -20.2% 1,170,869 $2.3M
MMCAP International Inc. SPC 0.22% Reduce -13.9% 795,625 $1.6M
Lion Street Advisors, LLC 0.19% Add +7.9% 273,281 $544K
Foundations Investment Advisors, LLC 0.01% Add +237.4% 161,950 $321K
Knoll Capital Management, LLC 0.09% No change 100,000 $198K
Mgo One Seven LLC 0.01% No change 100,000 $198K
Morgan Stanley 0.00% Add +133.3% 63,700 $126K
Cambridge Investment Research Advisors, Inc. 0.00% Reduce -47.5% 61,001 $121K
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 0.00% No change 55,000 $109K
Geode Capital Management, LLC 0.00% No change 52,435 $104K
Bank of Montreal 0.00% Reduce -0.2% 50,000 $103K
Marble Harbor Investment Counsel, LLC 0.01% No change 36,900 $73K
Goldman Sachs Group Inc. 0.00% Add +53.6% 36,100 $71K
Wealthspire Advisors, LLC 0.00% New 30,302 $60K
Susquehanna International Group, LLP 0.00% Reduce -61.7% 25,346 $50K
Group One Trading LLC 0.00% Reduce -12.2% 24,840 $49K
Two Sigma Investments, LP 0.00% New 24,666 $49K
Royal Bank of Canada 0.00% Reduce -11.0% 24,130 $48K
Two Sigma Securities, LLC 0.00% New 16,916 $33K
Jane Street Group, LLC 0.00% New 14,759 $29K
Townsquare Capital LLC 0.00% New 13,745 $27K
Wealth Enhancement Advisory Services, LLC 0.00% New 13,700 $27K
LPL Financial LLC 0.00% New 13,310 $26K
TD Waterhouse Canada Inc. 0.00% No change 6,900 $14K
Citadel Advisors 0.00% Reduce -76.2% 6,221 $12K
Piscataqua Savings Bank 0.01% No change 5,000 $10K
Valley National Advisers Inc. 0.00% No change 5,000 $9K
Hartford Financial Management Inc. 0.00% No change 4,000 $8K
Bank of America Corp. 0.00% No change 4,000 $8K
UBS Group AG 0.00% Add +6.0% 2,650 $5K
JPMorgan Chase & Co. 0.00% New 2,500 $5K
Wells Fargo & Company 0.00% Reduce -33.3% 2,000 $4K
Osaic Holdings, Inc. 0.00% No change 1,200 $2K
Rise Advisors, LLC 0.00% No change 1,000 $2K
SouthState Bank Corp 0.00% No change 1,000 $2K
Painted Porch Advisors LLC 0.00% No change 500 $990
CENTRAL TRUST Co 0.00% New 400 $792
Huntington National Bank 0.00% New 241 $477
National Bank of Canada 0.00% Reduce -89.9% 202 $400
Stone House Investment Management, LLC 0.00% No change 50 $99

"% of holder's portfolio" is CRDL's weight in each manager's 13F, not the share of Cardiol Therapeutics Inc. Class A the manager owns.